Sign Up
OverviewAPI
The global oncology drugs market is poised to grow at an 11.53% CAGR, reaching $474.06 billion by 2030, fueled by rising cancer cases and treatment advancements. Companies like Bristol Myer Squibb and GlaxoSmithKline are actively pursuing R&D and M&A activities. Targeted therapy dominates, with North America leading due to high cancer rates and superior healthcare infrastructure.

Ask a question